Patent Assignment Details
NOTE:Results display only for issued patents and published applications.
For pending or abandoned applications please consult USPTO staff.
|
| Reel/Frame: | 062922/0856 | |
| Pages: | 5 |
| | Recorded: | 03/08/2023 | | |
| Attorney Dkt #: | Q285383 |
| Conveyance: | ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS). |
|
|
Total properties:
1
|
|
|
|
Patent #:
|
NONE
|
Issue Dt:
|
|
Application #:
|
18025322
|
Filing Dt:
|
03/08/2023
|
|
Publication #:
|
|
Pub Dt:
|
10/12/2023
| | | | |
|
Title:
|
USE OF CHIAURANIB IN COMBINATION WITH IMMUNE CHECKPOINT INHIBITOR IN ANTITUMOR THERAPY
|
|
|
Assignees
|
|
|
|
|
| 21F-24F, BUILDING B, ZHIGU INDUSTRIAL PARK |
| SHUGUANG COMMUNITY, XILI STREET, NANSHAN DISTRICT SHENZHEN |
| GUANGDONG, CHINA 518057 |
|
|
|
|
|
| NO. 18, XINTONG SOUTH 1ST ROAD, HIGH-TECH ZONE |
| CHENGDU, SICHUAN, CHINA 610000 |
|
|
Correspondence name and address
|
| |
SUGHRUE MION, PLLC
|
| |
2000 PENNSYLVANIA AVENUE, N.W.
|
| |
SUITE 9000
|
| |
WASHINGTON, DC 20006
|
Search Results as of:
05/30/2024 01:57 PM
If you have any comments or questions concerning the data displayed,
contact
PRD / Assignments at 571-272-3350. v.2.6
Web interface last modified:
August 25, 2017 v.2.6
|
